Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effects of L-Carnitine Supplementation on Lipid Concentrations in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Publisher



Asbaghi O1 ; Kashkooli S2 ; Amini MR3, 4 ; Shahinfar H3 ; Djafarian K5 ; Clark CCT6 ; Shabbidar S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
  2. 2. Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  3. 3. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran
  5. 5. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Centre for Intelligent Healthcare, Coventry University, Coventry, CV15FB, United Kingdom

Source: Journal of Cardiovascular and Thoracic Research Published:2020


Abstract

This meta-analysis was performed to assess the effect of L-carnitine supplementation on lipid profile. A systematic search were conducted in PubMed and Scopus to identify randomized clinical trials (RCTs) which evaluated the effects of L-carnitine on lipid profile. Pooled effect sizes were measured using random-effect model (Dersimonian-Laird). Meta-analysis showed that L-carnitine supplementation significantly reduced total cholesterol (TC) (weighted mean difference [WMD]: -8.17 mg/dL; 95% CI, -14.68 to -1.65, I2=52.2%, P= 0.041). Baseline level of TC was a source of heterogeneity, with a greater effect in studies with a baseline level of more than 200 mg/d (WMD: -11.93 mg/dL; 95% CI, -20.80 to -3.05). L-carnitine also significantly decreased low-density lipoprotein-cholesterol (LDL-C) (WMD: -5.22 mg/dL; 95% CI, -9.54 to -0.91, I2=66.7%, P= 0.010), and LDL-C level <100 mg/dL), trial duration, and L-carnitine dosage were potential sources of heterogeneity. L-carnitine supplementation appeared to have no significant effect on high-density lipoprotein-cholesterol (HDL-C) (WMD: -0.51 mg/dL; 95% CI, -2.45 to 1.44) and triglyceride (TG) (WMD: 2.80 mg/dL; 95% CI, -8.09 to 13.69). This meta-analysis revealed that L-carnitine may have favorable effects on lipid profile, especially LDL-C and TC. However, further RCTs are needed to confirm the veracity of these results, particularly among hyperlipidemic patients. © 2020 The Author (s). This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Experts (# of related papers)
Other Related Docs
42. The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis, International Journal for Vitamin and Nutrition Research (2025)
50. Water Intake and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021)